From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.81
First Reported 1990
Last Reported 2009
Negated 0
Speculated 0
Reported most in Abstract
Documents 4
Total Number 5
Disease Relevance 1.09
Pain Relevance 0.44

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transmembrane transporter activity (AQP1) plasma membrane (AQP1) nucleus (AQP1)
transmembrane transport (AQP1) cytoplasm (AQP1)
Anatomy Link Frequency
muscle 1
pancreatic ducts 1
AQP1 (Homo sapiens)
Pain Link Frequency Relevance Heat
anesthesia 1 99.40 Very High Very High Very High
dopamine receptor 1 98.88 Very High Very High Very High
Chronic pancreatitis 2 83.88 Quite High
Catecholamine 2 75.00 Quite High
cva 6 66.36 Quite High
fibrosis 1 54.72 Quite High
ketamine 4 44.96 Quite Low
Pain 2 40.04 Quite Low
headache 1 25.00 Low Low
Disease Link Frequency Relevance Heat
Heart Rate Under Development 16 92.96 High High
Stroke 8 86.00 High High
Pancreatitis 3 83.88 Quite High
Hypertension 97 75.12 Quite High
Cv General 3 Under Development 6 66.36 Quite High
Pneumoperitoneum 6 63.04 Quite High
Critical Illness 8 5.00 Very Low Very Low Very Low
Compartment Syndromes 2 5.00 Very Low Very Low Very Low
Injury 2 5.00 Very Low Very Low Very Low
Headache 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Exocrine function test revealed that fluid secretion was severely impaired in AIP. immunohistochemical analysis revealed that AQP1 is localized mainly in the apical and lateral membranes of small pancreatic ducts in control subjects.
Localization (localized) of AQP1 in pancreatic ducts
1) Confidence 0.81 Published 2009 Journal J. Med. Invest. Section Abstract Doc Link 20224214 Disease Relevance 0.23 Pain Relevance 0.19
Methods: PulseCO was calibrated by TEE after induction of anesthesia, and PulseCO and continuous cardiac output with Vigilance (CCO) were measured continuously.
Localization (calibrated) of PulseCO in CCO associated with anesthesia
2) Confidence 0.17 Published 2009 Journal Masui Section Abstract Doc Link 19364001 Disease Relevance 0 Pain Relevance 0.10
Calibration of PulseCO was performed before muscle relaxation, because neuromuscular blockers may react with the lithium electrode.

Localization (Calibration) of PulseCO in muscle
3) Confidence 0.05 Published 2008 Journal Crit Care Section Body Doc Link PMC2592771 Disease Relevance 0.53 Pain Relevance 0
In contrast to PulseCO, PCCO was calibrated at each experimental step.
Localization (calibrated) of PulseCO
4) Confidence 0.02 Published 2008 Journal Crit Care Section Body Doc Link PMC2592771 Disease Relevance 0.25 Pain Relevance 0.06
Co-dergocrine mesylate (Cod), which inhibits norepinephrine secretion by stimulating presynaptic dopamine receptors, and has no known metabolic side effect, has an additive antihypertensive effect to that of Nifedipine (Nif).
Localization (secretion) of Co-dergocrine associated with dopamine receptor
5) Confidence 0.00 Published 1990 Journal Eur. J. Clin. Pharmacol. Section Abstract Doc Link 2076734 Disease Relevance 0.07 Pain Relevance 0.09

General Comments

This test has worked.

Personal tools